The controlled cell line combined with Recipharm’s AAV manufacturing platform is said to allow for consistent and scalable ...

Despite biotech's struggles, quality and global diversification create opportunities in select names. Read why portfolio ...

Post patent expiry, numerous Indian companies launched generic versions of Empagliflozin. The market witnessed a surge in ...

Colorado’s life sciences sector is growing, but leaders warn federal delays, housing costs and demographic shifts could ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

How Praxis Packaging delivers flexible, reliable solutions for pharmaceutical contract packaging needs. As pressures on ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Neurocrine Biosciences has handed back two discovery-stage gene therapy programs to Voyager Therapeutics, although the ...

Astorg has agreed to buy a majority stake in Solabia Group, a global biotechnology ingredients provider, from TA Associates.

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...